Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma

NCT04871334 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma
Advanced Urothelial Carcinoma

Interventions

DRUG: TWP-101

Sponsor

Shandong TheraWisdom Biopharma Co., Ltd.